PXL-770

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NamePXL-770
Drug Alias NamePXL-770
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsMetabolic DiseasesAdrenoleukodystrophyMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPoxel Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScynexis IncPoxel Sa
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesAdrenoleukodystrophyMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A